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Objective; This study aimed to explore practices among healthcare professionals in 
nonsteroidal anti-inflammatory drug (NSAID) information provision.  
Methods; In-depth interviews were conducted with orthopaedic physicians, hospital and 
community pharmacists in northeastern Thailand. Ten hospitals and twenty pharmacies in 
five provinces were purposively selected. Interviews followed a topic guideline, were audio-
recorded, transcribed verbatim and analyzed using a framework approach.  
Key findings; Fifty-one participants were involved: 13 orthopedic physicians, 20 hospital 
pharmacists and 18 community pharmacists. Four main themes emerged: general 
information, safety information, differences between new and regular NSAID users and non-
selective and selective NSAID users. Pharmacists mostly provided information on 
administration and indication. While all three groups informed of adverse effects, this was 
selective, related to factors including trading, time available, patients’ age, and perceived 
ability to understand. Gastrointestinal adverse effect information was most commonly 
provided, with other side effects, drug interactions and need to monitor for adverse effects 
rarely mentioned. Variation was reported in provision of safety information depending on 
whether patients were using selective or non-selective NSAIDs, and new or long-term users.   
Conclusions; The content and frequency of NSAID information provision varied between 
health professionals. Greater awareness of NSAID risks is essential, therefore strategies to 
improve information provision to Thai patients are desirable. 
Key words: healthcare professionals, Thailand, practice experience, nonsteroidal anti-





Nonsteroidal anti-inflammatory drugs (NSAIDs) are in widespread use for pain and 
inflammatory conditions. Many are accessible without a prescription, especially in pharmacy 
settings, where NSAIDs are frequently purchased.[1-5] However, there are potentially serious 
long-term risks associated with using NSAIDs, in addition to the well-known side effects, 
about which those using these medicines should be informed.[6, 7] Studies in many countries 
show that awareness of side effects and risks associated with NSAIDs among those who use 
them is poor.[1, 3, 4, 8-14]  In Thailand, more than in many other countries, this group of drugs is 
widely available since they can be purchased without prescription from pharmacies, and 
NSAIDs are extensively used.[15] Not surprisingly therefore, NSAIDs are consistently 
reported to the Thai Food and Drug Administration (Thai FDA) as the second most frequent 
cause of adverse effects.[16] 
Our previous surveys have shown that both hospital pharmacists (HPs) and orthopedic 
physicians (OPs) in Thailand have positive attitudes towards the provision of information to 
patients about the risks associated with NSAIDs.[17, 18] Approximately 75% of OPs and 84% 
of HPs claimed to provide patients with information about side effects, mainly 
gastrointestinal problems, and over 80% of both groups saw patient information leaflets 
(PILs) provided with medicines as appropriate useful sources for improving risk and benefit 
information. Our community pharmacist (CP) survey found that most claimed to screen 
patients for factors which could increase NSAID risks when supplying non-selective COX-2 
NSAIDs, but did so less often if supplying selective NSAIDs.[19] They were also less likely to 
provide information and advice about side effects with supply of selective NSAIDs than for 
non-selective drugs.[19] Patients on the other hand have indicated that, while the majority 
receive information about how to use NSAIDs and their indication, fewer than half report 
receiving information about side effects and they perceive the risks of NSAIDs as generally 
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low.[20] The findings from this survey do however concur with those of health professionals, 
in that attitudes towards receiving written information in the form of PILs were positive.[21] 
Such leaflets are not however widely available in Thailand, despite evidence that they can 
improve patient knowledge of medicines.[22] A small survey of PILs for NSAIDs in 
community pharmacies showed that these are not generally available for locally 
manufactured generic products.[23] The majority of leaflets which were available were aimed 
at prescribers, not patients and none conformed to Thai regulatory requirements.  
A US study found that physicians and pharmacists are the information sources 
regarding NSAID risks that most NSAID users prefer to access,[24] while almost all Thai 
patients considered both professional groups had a role to play in providing information 
about ADRs.[21] Moreover, studies in the US and Canada show that both play major roles in 
communicating with patients to improve their awareness of these risks and their 
recommendations can affect patients’ choices in purchasing an NSAID over the counter.[9,10] 
Other US studies have found that, in practice, only half of the elderly who were prescribed 
NSAIDs received counseling from healthcare providers at their last consultation,[25] and that 
the majority of healthcare providers only provide some details about medication to patients, 
with administration being given priority over warnings about adverse effects and risks.[26] 
One survey, in Greece, attributed low awareness of possible NSAID risks in patients with 
comorbidity, especially those at risk of cardiovascular events, to insufficient communication 
between patients and healthcare professionals.[14] 
However, our surveys of Thai health professionals have identified a range of factors 
affecting self-reported information provision in addition to the type of NSAID. These include 
work setting, number of work colleagues, time available for direct patient contact and 
gender.[17-19] Our patient survey also found that the duration of NSAID use and age were 
factors which affected whether or not they had received information about potential side 
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effects and how to avoid or manage these.[20] Some of the practices appeared inappropriate in 
the light of current knowledge of NSAID risks. For example, younger patients reported 
receiving information more frequently than older patients and intermittent users more than 
regular users,[20] while community pharmacists advocated differing management of side 
effects depending on type of NSAID.[19] Thus it appears that studies in different countries find 
that not all important issues about NSAIDs are communicated to all patients, especially risk 
information, yet no qualitative studies have attempted to gain an insight into why this may be 
the case. We therefore sought to gain more understanding of the factors which affect the 
provision of information on these medicines by health professionals. 
The aim of this study was to explore decision-making, prioritization and reasons for 
this in relation to provision of information to patients about the risks of NSAID among 
orthopedic physicians, hospital pharmacists and community pharmacists, and to assess 
similarities and differences among these groups. 
 
Methods 
Study design and setting 
This qualitative research was conducted using in-depth interviews, which were carried out by 
one researcher over a five-month period (May–August 2015). Simple random sampling was 
used to select five of the twenty provinces in the northeastern region of Thailand: Kalasin, 
Khon Kaen, Sakon Nakhon, Surin, and Ubon Ratchathani. The study was approved by the 
Ethics Committee for Human research, Khon Kaen University. Reference number 
HE551130. Several levels of healthcare setting exist in Thailand: primary care units, 
community hospitals, general or secondary hospitals, and tertiary hospitals, while the private 
sector includes private clinics, private hospitals and pharmacies. Some community 
pharmacies are accredited by the Pharmacy Council and provide a higher level of services 
6 
 
than non-accredited pharmacies. There are three health insurance programs within the public 
sector: the Universal Coverage Scheme (UCS), Civil Servants Medical Benefits. Scheme 
(CSMBS), and Social Health Insurance Scheme (SHI). NSAIDs are accessible to patients 
registered with all three schemes. 
Participants 
Three groups of healthcare professionals that share responsibility for providing NSAIDs to 
patients in practice were included to explore their perceived roles in also providing 
information about NSAIDs: OPs, HPs and CPs. Purposive sampling was used to identify 60 
potential participants, 20 in each group. In each province, two hospitals and two community 
pharmacies were purposively selected, to include in each province, representation of both  
urban and  rural areas, and for community pharmacies a Thai Pharmacy Council accredited 
and non accredited pharmacy. Community pharmacies which did not supply both non-
selective and selective NSAID products, and rural hospitals which had no OPs were 
excluded. Potential participants were invited to take part and to make an appointment for 
interview by telephone. We identified the participants by convenient sampling from selected 
sites. The target recruited healthcare professionals in each site consisted of 2 pharmacists and 
2 orthopedic physicians. If a participant could not be recruited from the selected site, another 
participant at the same site would be approached to achieve the target number. However, if 
there was only one participant (physician) working at the site, we selected only one 
participant. A letter was sent to all those who verbally indicated they were willing to 
participate, confirming the interview appointment. 
Interview content 
A guideline for the interview was developed to elicit individuals’ experiences of providing 
information about NSAIDs to their patients, to gain insight into the risk information given. 
The topic guideline was based on literature review and gaps found in previous studies.[17-19] 
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The guideline was assessed for face validity by three pharmacists, who confirmed that it 
represented the study objectives, and any minor problems revised before collecting data. The 
topics included were: details of NSAID information provided to patients, with emphasis on 
adverse effects; criteria used for screening and selecting patients for prescribing or supply of 
NSAIDs; and opinions on provision of NSAID risk information to patients. 
Data collection 
Face-to-face semi-structured interviews were conducted in Thai language with consented 
participants, at their place of work, or other location chosen by participants. All were audio-
recorded with consent. The researcher recorded reflections on the interviews as field notes 
immediately after each interview. 
Data analysis 
All interview records along with the field notes were transcribed in Thai by Researcher 1, and 
transcripts re-checked for accuracy by researcher 2. Next, the transcripts were translated into 
English, and the accuracy of translation was checked first by researcher 2, then checked 
independently by researcher 3. Initially, the data were subjected to framework analysis to 
develop codes, based on the themes in the interview guideline. Researcher 1 and researcher 2 
independently read and generated subthemes from transcripts, and all generated subthemes 
were discussed and agreed upon. Following this, the emergent sub-themes with new codes 




A total of 51 healthcare professionals agreed to participate in the study: 13 OPs (response rate 
65%), 20 HPs (100%), ten working mainly in out-patient units and ten in in-patient units, and 
18 CPs (90%). Participants’ demographic data are summarized in Table 1. More than half of 
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all participants were female, with both hospital and community pharmacists having a 
majority of females. In contrast, only two of the 13 physicians were female. Age distribution 
also differed between the groups, with half of the community pharmacists being under 30 
years of age, in contrast to only two of the physicians, and physicians had less work 
experience than the pharmacists.   
(Insert Table 1 here) 
Data saturation was achieved after interviewing 11 OPs, 15 HPs and 14 CPs. Interview 
duration ranged from 30 to 45 minutes. Four main themes emerged from the data: (1) general 
information about NSAIDs, (2) safety information related to NSAIDs (3) new NSAID users 
and regular NSAID users, and (4) non-selective NSAID users and selective NSAID users. 
Information was provided in general about NSAIDs, as well as safety information and that 
there were differences regarding the information given depending on whether patients were 
attending their first visit or a follow-up, and the type of NSAID (non-selective NSAIDs or 
selective COX-2 NSAIDs). The themes and subthemes are described below, with illustrative 
quotes identified by participant type and number.  
Theme 1: General information related to NSAIDs 
Under this theme, participants talked about the information they gave to patients 
concerning the indication for the NSAID, its selection and administration, including duration.  
- Subtheme 1: How to take this drug 
The majority of both HPs (14) and CPs (15) claimed that they provided general 
information to patients, but this seemed to be less common practice among OPs (4).  Most 
who did said they did not give special attention to patients receiving NSAIDs, except advice 
on taking after meals.  
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“For NSAIDs, I advise patients to take this drug immediately after meals, and I 
always give additional label on drug package to prevent [them]  forgetting directions 
of use. (HP_001, general hospital) 
- Subtheme 2: How long to take this drug 
Very few participants discussed duration of use (four CPs, three Ops), all of whom 
advised patients to take the drug short-term and to stop using NSAIDs when symptoms were 
relieved. 
“I tell patients that they should not take drug every day, or suggest duration of use for 
them. If their symptoms improve, I will suggest stopping the drug or using as needed.” 
(OP_003, community hospital) 
- Subtheme 3: The purpose of this drug 
Clarification of indication was explicitly mentioned by many of the pharmacists and 
some physicians. Interviewees described explaining about taking the NSAID for relief of 
pain. However, patients’ misperceptions concerning the drug’s indication were also 
highlighted. 
“I described its use as anti-inflammation. Some patients were confused that it was 
antibiotic drug, and I had to explain them about correct indication.” (CP_016, non-
accredited pharmacy) 
- Subtheme 4: Alternative drugs 
Four of the OPs also discussed how they made decisions about selecting a NSAID for 
patients, which went beyond patient characteristics, to include their finance, type of insurance 
and type of hospital. 
“At first, I really consider patients' age and severity of pain before evaluating the 




Theme 2: Safety information related to NSAIDs 
- Subtheme 1: Side effects 
Most participants talked about providing information about side effects from 
NSAIDs; 10 OPs, 16 HPs, and 13 CPs. However, three (two CPs and a physician) said they 
did not provide side effects information to their patients. 
“I do not tell side effects of NSAIDs to patients because this is a major trading [issue] . 
When I tell them this drug has side effects, they will fear and not purchase it.” 
(CP_005, accredited pharmacy) 
Patient education about potential side effects mainly covered gastrointestinal (GI) side 
effects, often minimized in hospitals by the use of a proton-pump inhibitor, however, some 
interviewees mentioned that even this information was not provided to all patients, depending 
on age, potential for understanding or time. 
“I only inform patients about stomach irritation. In hospital, patients are mostly 
prescribed NSAID with omeprazole. I usually advise all older patients, but not 
younger adults.” (HP_019, tertiary hospital) 
There were seven physicians and two CPs who claimed to highlight potential for renal 
side effects from NSAIDs to their patients, while three HPs mentioned they did not inform 
patients about renal side effects, except if patients ask. 
“I inform patients about side effects on their kidney, especially in patients with renal 
disease, elderly, tend to have more underlying disease.” (OP_003, community 
hospital) 
Few in each group said they informed patients about potential cardiovascular (CV) 
side effects (two OPs, one HP, two CPs). However, the physicians said they only provide this 
information for selective COX-2 NSAID users.  
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“If I prescribed celecoxib to patients, I describe information about CV side effects to 
them when using in long term.” (OP_006, community hospital) 
Two OPs and two HPs, but no CP, said they inform patients about drug allergy and 
what to do if it occurs. 
“I asked question about allergy history, in addition, I told them “If you have rash, 
difficult breathing or any allergy symptoms, stop using this drug immediately” 
(HP_012, general hospital) 
- Subtheme 2: Interactions between drugs 
Only one OP and one CP mentioned discussing the possibility of drug interactions 
with patients, including duplication of NSAIDs. 
“I told them to be careful about other drugs or double-dose of NSAIDs. If they were 
taking other drugs for pain diseases, I tell them to stop using those drugs.” (OP_006, 
community hospital) 
- Subtheme 3: Monitoring for side effects 
This was only covered by two CPs, one of whom specified the abnormal symptoms 
that meant patients should return. 
“I informed patients about "If you frequently feel burning sensation in your stomach, 
you should come back to any community pharmacy to receive gastro-protective 
drugs" (CP_005, accredited pharmacy) 
Theme 3: Differences between new NSAID users and regular NSAID users 
Ten of those interviewed said their practice was the same for both patients receiving an 
NSAID for the first time and those who were regular users. HPs claimed it was difficult to 




“It is similar in providing information in all cases. In prescription of NSAIDs, I 
advise patients to take drug when they have symptoms and do not take it every day.” 
(OP_010, community hospital) 
- Subtheme 1: Amount of information 
In contrast, 15 (eight HPs, four CPs and three OPs) described differences, some 
indicating that they provided more detailed information for new NSAID users and others that 
increasing information was given with longer duration of use. 
“In patients initially prescribed NSAIDs, I would rather provide them with a lot of 
information. However, this information was well-known in regular cases.” (HP_002, 
general hospital) 
- Subtheme 2: Additional information 
One important difference in information provision between new and regular users was 
mentioned by eight participants (four CPs and four OPs) who said they provided some extra 
information to continuous users, which they did not give to new users. These covered 
alternative ways for managing pain and inflammation, and risks to the kidney with long-term 
use. 
“In regular users, I say about long-term use of NSAIDs may affect their kidneys, 
particularly in patients on long-term treatment with NSAIDs for 1-2 years.” (OP_002, 
community hospital) 
Theme 4: Between non-selective NSAID users and selective NSAID users 
Differences in the provision of safety information related to NSAIDs dependent on 
whether patients received non-selective NSAID users and selective NSAID users was 
highlighted by many participants, but eleven (six HPs, three CPs and two OPs) said they offer 
the same information regardless of NSAID type. 
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“I informed only if this was new drug group or older, …because mostly customers 
were not interested in depth of these details.” (CP_001, non-accredited pharmacy) 
- Subtheme 1: Side effects 
Other participants did claim to provide different information, especially for GI side 
effects, with thirteen (six HPs, two CPs, five OPs) explaining to patients about reduced 
incidence of GI side effects in selective NSAIDs. This confidence in the reduced potential for 
problems extended as far as some providing no information. 
“When patients were prescribed a new group of NSAIDs, I informed about this drug 
had lower GI side effects but for safety patients should take it after meals" (HP_005, 
general hospital) 
In contrast, three specifically informed patients about CV problems with selective 
NSAIDs (two CPs and one OP) and one on renal effects. 
“I told openly to them that this drug [celecoxib]  had side effect on heart. When I 
informed them, they feel accepted and well-understood. They were not anxious to 
discontinue.” (OP_006, community hospital) 
- Subtheme 2: Drug costs 
In addition to information about potential side effects, two CPs also mentioned 
providing information about drug costs. 
“For a new class of NSAIDs, their prices were very high with less side effects. I have 
to clarify patients about this drug choice. The decision was up to the customer. 
(CP_018, accredited pharmacy) 
 
Discussion 
Information communicated to patients using NSAIDS varied between different health 
professionals, but also depended on type of NSAID and duration of use. Pharmacists in both 
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hospital and community provided general information on administration and indication, 
which was consistent with our previous survey of NSAID users, a high proportion of whom 
reported receiving such information. [21] However, the present study suggests physicians did 
not always offer this information, which may contribute to the apparent confusion, mentioned 
by some pharmacists. 
Although most interviewees claimed they informed patients of adverse effects, this 
was selective, as has been found elsewhere,[9,11] emphasising GI complications. This was also 
reflected in our survey of NSAID users, fewer than half of whom recalled receiving 
information about adverse effects. [21] Reasons given for providing selected information 
varied, but included trading, time available, patients’ age and their perceived ability to 
understand. Many did not discuss additional risks with their patients, raising concerns that 
such information may lead to lower adherence in some patients, which confirmed previous 
findings from our surveys of Thai HPs and OPs.[17,18] 
While ideally all NSAID users should be informed about all potential adverse effects, 
realistically this may be difficult in practice. Hence varying the amount of information given 
to different patient groups may be a useful strategy. Perceptions that too much information 
could reduce understanding, or affect adherence have been expressed by health professionals 
in Thailand and elsewhere.[17,18,27] The health professionals in our study managed potential 
information overload by providing information on renal and CV risks only to patients 
requesting this information, or to selected groups, such as the elderly or those with underlying 
disease. Reserving detailed discussion of less common side effects and longer term risks for 
regular NSAID users, as was the practice of some participants, also seems reasonable and has 
been reported elsewhere.[28] 
The practice we found of expounding lower GI side effects with selective NSAIDs 
while not informing about other issues, and indeed failing to inform patients of potential 
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adverse effects to influence their purchasing decision, is less justifiable. This is of particular 
concern for patients receiving healthcare through the UCS and SHI health schemes, who can 
receive free medicines from the National Essential Medicines List, including non-selective 
NSAIDs, but not selective NSAIDs, for which they must pay. This practice may lead the 
public to believe that selective NSAIDs are better and safer to use. Clearly type of NSAID 
was a factor affecting other aspects of information provision, again confirming some of our 
survey results.[19,20] CV side effects were only mentioned by a few participants in relation to 
selective NSAIDs and not with non-selective drugs, despite similar risks.[6] The cost of 
obtaining different NSAIDs, of immediate relevance to purchasers, was an additional aspect 
of information provision related to type of NSAID, and also affected decisions about 
selection by OPs and CPs. 
Explaining the need to avoid duplicating NSAIDs was mentioned by only two 
interviewees, despite the potentially dangerous combination of prescription and non-
prescription NSAIDs being widespread.[26] Few interviewees referred to the need to avoid 
NSAIDs or use them short-term in older people or to exercise caution in patients with risk 
factors or concomitant drug use which could increase their chances of adverse 
events.[3,4,12,13,20,29-31] The potential for acute effects on the kidney[7] were only discussed in 
long-term users. 
Patients value healthcare professionals as important sources of information, even 
though in many countries other sources can be easily accessed.[22,32,33] Although the failure to 
inform patients in full about risks may reasonably be related to decisions about the quantity 
of information, when to provide it and its necessity in short term users, there is a need for 
greater provision. Written information provided with all purchased medicines, as occurs 
elsewhere, would give all users of NSAIDs accessible risk information, regardless of NSAID 
type, duration of use or patient characteristics. 
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This study was limited to five of the 77 provinces in Thailand. The majority of 
pharmacists in our study were female, in contrast to the physicians, who were mostly male 
and the age distribution and work experience differed between pharmacists and physicians, 
most likely due to the time taken to qualify for the latter positions. As with any qualitative 
study the results cannot be generalized to healthcare practice in Thailand more widely. 
Moreover, the interviews required participants to generalize their practices and the 
information they gave was subject to recall bias and could not be verified. Although we were 
not able to undertake validation of the transcriptions or seek interviewee views on our 
interpretation, all interviews were reviewed by two researchers and themes discussed by all 
authors. 
Conclusion  
The content and frequency of information provision varied between health professionals and 
was affected by duration and type of NSAID, as well as patient factors. Pharmacists provided 
general information more than physicians and, while all three groups discussed side effects, 
they mostly concentrated on GI effects. Important information about potential drug-drug 
interactions, other adverse effects and how to monitor for these was often overlooked. 
Greater attention should be paid by all health professions to providing information about 
NSAID risks to help reduce adverse events. The provision of PILs with medicines could 
improve available information for patients. 
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Table 1 Participants’ demographic data 
Demographic variable 










Sex    
Female  2 15 12 
Male 11  5   6 
Age (years)    
≤ 30  2 7 9 
31-40 9 9 8 
41-50 1 4 0 
51-60 1 0 1 
Mean (S.D.) 37.31±7.99 32.75±6.45 32.67±7.51 
Min-Max 27-60 25-47 26-55 
Working area    
Rural areas 6 10 9 
Urban areas 7 10  9 
Work experience (years)    
≤ 5 2 7 10 
6-10 8 6  2 
> 10 3 7  6 
Mean (S.D.) 10.31±8.43 9.70±6.43 9.11±9.02 
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